EUVIMEDEUVIMED entdecken
Crossref

Anticonvulsant effect of equilibrative nucleoside transporters 1 inhibitor in a mouse model of Dravet syndrome

Shih-Yin Ho iD, I-Chun Chen, Che-Wen Tsai, Kai-Chieh Chang iD, Chun-Jung Lin, Yijuang Chern, Horng-Huei Liou

Hippocampus · 2024

DOI: 10.1002/hipo.23584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hippocampus, 2024. Verfasst von Shih-Yin Ho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic, Epilepsy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, National Taiwan University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are limited therapeutic options for patients with Dravet syndrome (DS). The equilibrative nucleoside transporters 1 (ENT1) mediate both the influx and efflux of adenosine across the cell membrane exerted beneficial effects in the treatment of epilepsy. This study aimed to evaluate the anticonvulsant effect of the ENT1 inhibitor in an animal model of DS (Scn1a E1099X/+ mice). J7 (5 mg/kg) treatment was efficacious in elevating seizure threshold in Scn1a E1099X/+ mice after hyperthermia exposure. Moreover, the J7 treatment significantly reduced the frequency of spontaneous excitatory post‐synaptic currents (sEPSCs, ~35% reduction) without affecting the amplitude in dentate gyrus (DG) granule cells. Pretreatment with the adenosine A1 receptor (A1R) antagonist, DPCPX, abolished the J7 effects on sEPSCs. These observations suggest that the J7 shows an anticonvulsant effect in hyperthermia‐induced seizures in Scn1a E1099X/+ mice. This effect possibly acts on presynaptic A1R‐mediated signaling modulation in granule cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, MyoclonicEpilepsyHumansMiceAnimalsAnticonvulsantsNucleosidesNeuronsDisease Models, AnimalNAV1.1 Voltage-Gated Sodium Channel

Stichwörter der Autor:innen

A1RENT1Scn1afebrile seizurepatch-clamp

Substanzen

AnticonvulsantsNucleosidesScn1a protein, mouseNAV1.1 Voltage-Gated Sodium Channel

Autor:innen und Institutionen

  • Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Graduate Institute of Biomedical and Pharmaceutical Science, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan.
  • Department of Neurology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei, Taiwan.
  • Department of Neurology, National Taiwan University Hospital Yunlin Branch, Douliu, Taiwan.
  • School of Pharmacy, National Taiwan University, Taipei, Taiwan.

ORCID-Profile: Shih-Yin Ho, Kai-Chieh Chang

Förderung

  • Ministry of Science and Technology, Taiwan
  • National Taiwan University Hospital

Zitieren

APA

Ho, S. Y., Chen, I. C., Tsai, C. W., Chang, K. C., Lin, C. J., Chern, Y., & Liou, H. H. (2024). Anticonvulsant effect of equilibrative nucleoside transporters 1 inhibitor in a mouse model of Dravet syndrome. Hippocampus. https://doi.org/10.1002/hipo.23584

Vancouver

Ho SY, Chen IC, Tsai CW, Chang KC, Lin CJ, Chern Y, et al. Anticonvulsant effect of equilibrative nucleoside transporters 1 inhibitor in a mouse model of Dravet syndrome. Hippocampus. 2024. doi:10.1002/hipo.23584

BibTeX
@article{Ho2024,
  author = {Ho, Shih-Yin and Chen, I-Chun and Tsai, Che-Wen and Chang, Kai-Chieh and Lin, Chun-Jung and Chern, Yijuang and Liou, Horng-Huei},
  title = {Anticonvulsant effect of equilibrative nucleoside transporters 1 inhibitor in a mouse model of Dravet syndrome},
  journal = {Hippocampus},
  year = {2024},
  doi = {10.1002/hipo.23584}
}
Kostenlos starten →